Artelo Biosciences Files 8-K: Material Agreement & Exhibits

Ticker: ARTL · Form: 8-K · Filed: Jul 18, 2025 · CIK: 1621221

Sentiment: neutral

Topics: material-agreement, filing, exhibits

Related Tickers: ARTL

TL;DR

ARTL 8-K filed: Material agreement entered, exhibits included. Watch for details.

AI Summary

On July 18, 2025, Artelo Biosciences, Inc. filed an 8-K report. The filing indicates an entry into a material definitive agreement and includes financial statements and exhibits. The company, formerly known as Reactive Medical Inc. and Knight Knox Development Corp., is incorporated in Nevada and headquartered in Solana Beach, California.

Why It Matters

This 8-K filing signals a significant development for Artelo Biosciences, Inc., potentially involving a new material agreement that could impact its business operations and financial standing.

Risk Assessment

Risk Level: medium — The filing of an 8-K for a material definitive agreement suggests a significant event, but without details on the agreement's nature, the risk level is moderate.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by Artelo Biosciences, Inc. on July 18, 2025?

The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided excerpt.

What are the key exhibits included in this 8-K filing?

The filing states that financial statements and exhibits are included, but the specific list or content of these exhibits is not detailed in the provided excerpt.

When was Artelo Biosciences, Inc. incorporated, and in which state?

Artelo Biosciences, Inc. was incorporated in Nevada.

What were the previous names of Artelo Biosciences, Inc.?

The company was formerly known as Reactive Medical Inc. and Knight Knox Development Corp.

Where are Artelo Biosciences, Inc.'s principal executive offices located?

The principal executive offices are located at 505 Lomas Santa Fe, Suite 160, Solana Beach, CA 92075.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 18, 2025 regarding ARTELO BIOSCIENCES, INC. (ARTL).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing